BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31932368)

  • 1. Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel
    Sinxadi P; Donini C; Johnstone H; Langdon G; Wiesner L; Allen E; Duparc S; Chalon S; McCarthy JS; Lorch U; Chibale K; Möhrle J; Barnes KI
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048.
    McCarthy JS; Donini C; Chalon S; Woodford J; Marquart L; Collins KA; Rozenberg FD; Fidock DA; Cherkaoui-Rbati MH; Gobeau N; Möhrle JJ
    Clin Infect Dis; 2020 Dec; 71(10):e657-e664. PubMed ID: 32239164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
    McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM
    Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial efficacy of MMV390048, an inhibitor of
    Paquet T; Le Manach C; Cabrera DG; Younis Y; Henrich PP; Abraham TS; Lee MCS; Basak R; Ghidelli-Disse S; Lafuente-Monasterio MJ; Bantscheff M; Ruecker A; Blagborough AM; Zakutansky SE; Zeeman AM; White KL; Shackleford DM; Mannila J; Morizzi J; Scheurer C; Angulo-Barturen I; Martínez MS; Ferrer S; Sanz LM; Gamo FJ; Reader J; Botha M; Dechering KJ; Sauerwein RW; Tungtaeng A; Vanachayangkul P; Lim CS; Burrows J; Witty MJ; Marsh KC; Bodenreider C; Rochford R; Solapure SM; Jiménez-Díaz MB; Wittlin S; Charman SA; Donini C; Campo B; Birkholtz LM; Hanson KK; Drewes G; Kocken CHM; Delves MJ; Leroy D; Fidock DA; Waterson D; Street LJ; Chibale K
    Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria.
    Mohammed R; Asres MS; Gudina EK; Adissu W; Johnstone H; Marrast AC; Donini C; Duparc S; Yilma D
    Am J Trop Med Hyg; 2023 Jan; 108(1):81-84. PubMed ID: 36509063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
    Phyo AP; Jittamala P; Nosten FH; Pukrittayakamee S; Imwong M; White NJ; Duparc S; Macintyre F; Baker M; Möhrle JJ
    Lancet Infect Dis; 2016 Jan; 16(1):61-69. PubMed ID: 26448141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with
    Collins KA; Rückle T; Elliott S; Marquart L; Ballard E; Chalon S; Griffin P; Möhrle JJ; McCarthy JS
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30858218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous Expression, Purification, and Functional Analysis of the
    Sternberg AR; Roepe PD
    Biochemistry; 2020 Jul; 59(27):2494-2506. PubMed ID: 32543181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.
    Barber BE; Fernandez M; Patel HB; Barcelo C; Woolley SD; Patel H; Llewellyn S; Abd-Rahman AN; Sharma S; Jain M; Ghoghari A; Di Resta I; Fuchs A; Deni I; Yeo T; Mok S; Fidock DA; Chalon S; Möhrle JJ; Parmar D; McCarthy JS; Kansagra K
    Lancet Infect Dis; 2022 Jun; 22(6):879-890. PubMed ID: 35247321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers.
    McCarthy JS; Rückle T; Elliott SL; Ballard E; Collins KA; Marquart L; Griffin P; Chalon S; Möhrle JJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers.
    Leong FJ; Zhao R; Zeng S; Magnusson B; Diagana TT; Pertel P
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6437-43. PubMed ID: 25136017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.
    McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ
    Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development.
    McCarthy JS; Marquart L; Sekuloski S; Trenholme K; Elliott S; Griffin P; Rockett R; O'Rourke P; Sloots T; Angulo-Barturen I; Ferrer S; Jiménez-Díaz MB; Martínez MS; Hooft van Huijsduijnen R; Duparc S; Leroy D; Wells TN; Baker M; Möhrle JJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3669-75. PubMed ID: 27044554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.
    van der Plas JL; Kuiper VP; Bagchus WM; Bödding M; Yalkinoglu Ö; Tappert A; Seitzinger A; Spangenberg T; Bezuidenhout D; Wilkins J; Oeuvray C; Dhingra SK; Thathy V; Fidock DA; Smidt LCA; Roozen GVT; Koopman JPR; Lamers OAC; Sijtsma J; van Schuijlenburg R; Wessels E; Meij P; Kamerling IMC; Roestenberg M; Khandelwal A
    Lancet Infect Dis; 2023 Oct; 23(10):1164-1174. PubMed ID: 37414066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria.
    White NJ; Duong TT; Uthaisin C; Nosten F; Phyo AP; Hanboonkunupakarn B; Pukrittayakamee S; Jittamala P; Chuthasmit K; Cheung MS; Feng Y; Li R; Magnusson B; Sultan M; Wieser D; Xun X; Zhao R; Diagana TT; Pertel P; Leong FJ
    N Engl J Med; 2016 Sep; 375(12):1152-60. PubMed ID: 27653565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study.
    McCarthy JS; Lotharius J; Rückle T; Chalon S; Phillips MA; Elliott S; Sekuloski S; Griffin P; Ng CL; Fidock DA; Marquart L; Williams NS; Gobeau N; Bebrevska L; Rosario M; Marsh K; Möhrle JJ
    Lancet Infect Dis; 2017 Jun; 17(6):626-635. PubMed ID: 28363636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers.
    McCarthy JS; Baker M; O'Rourke P; Marquart L; Griffin P; Hooft van Huijsduijnen R; Möhrle JJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2620-7. PubMed ID: 27272721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast Asia.
    Yang H; Wang J; Liu H; Li X; Nie R; Li C; Wang H; Wang Q; Cao Y; Cui L
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987144
    [TBL] [